Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma

Clinical Proteomics

Volumn 10, Issue 1, 2013, Pages

  Khan, Rizma ^a   Zahid, Saadia ^a   Wan, Yu Jui Yvonne ^b   Forster, Jameson ^b   Abdul Karim, A Bashar ^b   Nawabi, Atta M ^b   Azhar, Abid ^a   Rahman, M Ataur ^a   Ahmed, Nikhat ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Cytochrome b5A; ESI Q TOF MS MS mass spectrometry; Hepatocellular carcinoma; Proteomics; S nitrosylation; Two dimensional gel electrophoresis

Indexed keywords

ATP SUBUNIT DELTA; BIOLOGICAL MARKER; CYTOCHROME B5; CYTOCHROME B5A; HEMOGLOBIN BETA CHAIN; MEMBRANE PROTEIN; NUCLEAR MEMBRANE PROTEIN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; S NITROSOCYSTEINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NITROSYLATION; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SCORING SYSTEM; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

EID: 84902077551     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-10-6     Document Type: Article

References (54)

1. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. (Pubitemid 37518510)
2. Okuda K: Hepatocellular carcinoma. J Hepatol 2000, 32:225-237. (Pubitemid 30123637)
3. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750. (Pubitemid 29114292)
4. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH: Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994, 19:222-226. (Pubitemid 24302039)
5. Marquardt JU, Galle PR, Teufel A: Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy. Dtsch Med Wochenschr 2012, 137:855-860.
6. el Tazi M, Essadi I, M'rabti H, Touyar A, Errihani PH: Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci 2011, 3:167-175.
7. Dumpis U, Kovalova Z, Jansons J, Cupane L, Sominskaya I, Michailova M, Karayiannis P, Gardovska D, Viazov S, Ross S, Roggendorf M, Pumpens P: An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol 2003, 69:331-338. (Pubitemid 36158312)
8. Seow TK, Liang RC, Leow CK, Chung MC: Hepatocellular carcinoma: from bedside to proteomics. Proteomics 2001, 1:1249-1263.
9. Shin BK, Hong W, Hanash S: Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:407-413. (Pubitemid 38438258)
10. Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W: The management of hepatocellular carcinoma around the world: A comparison of guidelines from 2001 to 2011. Liver Int 2012, 32:1053-1063.
11. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT, Block T: A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers 2001, 17:179-189. (Pubitemid 34014697)
12. Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S: Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 2006, 130:1086-1097.
13. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF 3rd, Zhao Y: 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 2002, 1:117-124.
14. Mínguez B, Lachenmayer A: Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Marker 2011, 31:181-190.
15. Chan DW, Colantonio DA: Clinical proteomics:cancer diagnostics? J Clin Ligand Assay 2005, 28:35-37.
16. Zhang Z, Chan DW: Cancer proteomics:in pursuit of "true" biomarker discovery. (Editorial). cancer epidemiol. Biomark Prevent 2005, 14:2283-2286. (Pubitemid 41437825)
17. Song Y, Hao Y, Sun A, Li T, Li W, Guo L, Yan Y, Geng C, Chen N, Zhong F, Wei H, Jiang Y, He F: Sample preparation project for the subcellular proteome of mouse liver. Proteomics 2006, 6:5269-5277. (Pubitemid 44547165)
18. Lee TY, Chen YJ, Lu TC, Huang HD, Chen YJ: SNOSite: exploiting maximal dependence decomposition to identify cysteine S-nitrosylation with substrate site specificity. PLoSOne 2011, 6:e21849.
19. Majano PL, García-Monzón C, López-Cabrera M, Lara-Pezzi E, Fernández-Ruiz E, García-Iglesias C, Borque MJ, Moreno-Otero R: Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virusinduced gene upregulation. J Clin Invest 1998, 101:1343-1352. (Pubitemid 28166831)
20. Rahman MA, Dhar DK, Yamaguchi E, Maruyama S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H, Nagasue N: Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C viruspositive cases. Clin Cancer Res 2001, 7:1325-1332. (Pubitemid 32708688)
21. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC: Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci USA 2000, 97:12770-12775.
22. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916. (Pubitemid 32976162)
23. Gaston B, Singel D, Doctor A, Stamler JS: S -nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 2006, 173:1186-1193.
24. Foster MW, Hess DT, Stamler JS: Protein S - nitrosylation in health and disease: A current perspective. Trends Mol Med 2009, 15:391-404.
25. Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L: S -nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med 2010, 2(19):19ra13. doi:10.1126/scitranslmed.3000328.
26. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein Snitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6:150-166.
27. Liu L, Xu-Welliver M, Kanugula S, Pegg AE: Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res 2002, 62:3037-3043. (Pubitemid 34602391)
28. Fukumura D, Kashiwagi S, Jain RK: The role of nitric oxide in tumour progression. Nat Rev Cancer 2006, 6:521-534. (Pubitemid 43980541)
29. Pedrazzini E, Villa A, Longhi R, Bulbarelli A, Borgese N: Mechanism of residence of cytochrome b(5), a tail-anchored protein, in the endoplasmic reticulum. J Cell Biol 2000, 148:899-914.
30. Pandey AV, Miller WL: Regulation of 17, 20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 2005, 280:13265-13271. (Pubitemid 40517210)
31. Stringer RA, Strain-Damerell C, Nicklin P, Houston JB: Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos 2009, 37:1025-1034.
32. Schenkman JB, Jansson I: The many roles of cytochrome b5. Pharmacol Ther 2003, 97:139-152.
33. Porter TD: The roles of cytochrome b5 in cytochrome P450 reactions. J Biochem Mol Toxicol 2002, 16:311-316.
34. Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T: Roles of nadph-p450 reductase and apo- And holo-cytochrome b5 on xenobiotics oxidations catalyzed by 12 recombinant human cytochrome p450s expressed in membranes of Escherichia coli. Protein Expr Purif 2002, 24:329-337. (Pubitemid 35420057)
35. Miller WL, Auchus RJ: The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011, 32:81-151.
36. Blanc M, Hsieh WY, Robertson KA, Watterson S, Shui G, Lacaze P, Khondoker M, Dickinson P, Sing G, RodrÃguez-MartÃn S, Phelan P, Forster T, Strobl B, Muller M, Riemersma R, Osborne T, Wenk MR, Angulo A, Ghazal P: Host defense against viral infection involves interferon mediated downregulation of sterol biosynthesis. PLoS Biol 2011, 9:e1000598.
37. Finn RD, McLaughlin LA, Hughes C, Song C, Henderson CJ, Roland Wolf C: Cytochrome b null mouse: A new model for studying inherited skin disorders and the role of unsaturated fattyacids in normal homeostasis. Transgenic Res 2011, 20:491-502.
38. Abe K, Kimura S, Kizawa R, Anan FK, Sugita Y: Amino acid sequences of cytochrome b5 from human, porcine, and bovine erythrocytes and comparison with liver microsomal cytochrome b5. J Biochem 1985, 97:1659-1668. (Pubitemid 15008061)
39. Takematsu H, Kawano T, Koyama S, Kozutsumi Y, Suzuki A, Kawasaki T: Reaction mechanism underlying CMP-N-acetylneuraminic acid hydroxylation in mouse liver: formation of a ternary complex of cytochrome b5, CMP-N-acetylneuraminic acid, and a hydroxylation enzyme. J Biochem 1994, 115:381-386.
40. Guiard B, Groudinsky O, Lederer F: Homology between bakers' yeast cytochrome b2 and liver microsomal cytochrome b5. Proc Natl Acad Sci USA 1974, 71:2539-2543.
41. Guiard B, Lederer F: The "b5-like" domain from chicken- liver sulfite oxidase: A new case of common ancestral origin with liver cytochrome b5 and bakers' yeast cytochrome b5 core. Eur J Biochem 1977, 74:181-190. (Pubitemid 8062701)
42. Yantsevich AV, Gilep AA, Usanov SA: Mechanism of electron transfer in fusion protein cytochrome b5-NADH-cytochrome b5 reductase. Biochemistry (Mosc) 2008, 73:1096-1107.
43. Dunn TM, Haak D, Monaghan E, Beeler TJ: Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase/desaturase domain. Yeast 1998, 14:311-321. (Pubitemid 28138982)
44. Wai PY, Kuo PC: Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm. World J Clin Oncol 2012, 3:15-23.
45. Hanash SM: Biomedical applications of two dimensional electrophoresis using immobilized pH gradients: Current status. Electrophoresis 2000, 21:1202-1209. (Pubitemid 30230784)
46. Reymond MA, Sanchez JC, Hughes GJ, Günther K, Riese J, Tortola S, Peinado MA, Kirchner T, Hohenberger W, Hochstrasser DF, Köckerling F: Standardized characterization of gene expression in human colorectal epithelium by two dimensional electrophoresis. Electrophoresis 1997, 18:842-848.
47. Keyes SR, Alfano JA, Jansson I, Cinti DL: Rat liver microsomal elongation of fattyacids. J Biochem 1979, 254:7778-7784.
48. Gan L, von Moltke LL, Trepanier LA, Harmatz JS, Greenblatt DJ, Court MH: Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADHb5 reductase in variability of CYP3A activity in human liver microsomes. Drug Metab Dispos 2009, 37:90-96.
49. Lewis DF, Ito Y: Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions. Expert Opin Drug Metab Toxicol 2008, 4:1181-1186.
50. Blum H, Beier H, Gross HJ: Silver staining of proteins in polyacrylamide gels. Electrophoresis 1987, 8:93-99.
51. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
52. Asif AR, Oellerich M, Amstrong VW, Gross U, Reichard U: Analysis of the cellular Aspergillusfumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis. Electrophoresis 2010, 31:1947-1958.
53. Zhang B, Kirov S, Snoddy J: WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:741-748.
54. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C: STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:412-416.